Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Ionis Pharmaceuticals Inc, Common Stock

IONS

NSQ

$41.07

+$0.39

(0.96%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$5.99B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

705.23K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

985.03K

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.40

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$34.32 L

$54.44 H

$41.07

About Ionis Pharmaceuticals Inc, Common Stock

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	IONS	Sector	S&P500
1-Week Return	-1.16%	-	-
1-Month Return	-3.86%	-4.1%	-5.03%
3-Month Return	-19.49%	-0.06%	2.76%
6-Month Return	-10.31%	10.49%	18.67%
1-Year Return	14.98%	4.98%	21.87%
3-Year Return	-3.27%	18.95%	25.75%
5-Year Return	-43.46%	76.87%	85.4%
10-Year Return	11%	181.6%	217.58%

Time Frame	IONS	Sector	S&P500
1-Week Return	-45.58%	0.00%	0.00%
1-Month Return	-38.06%	-39.91%	-46.63%
3-Month Return	-58.49%	-0.24%	11.67%
6-Month Return	-19.80%	22.42%	41.50%
1-Year Return	14.98%	4.98%	21.87%
3-Year Return	-1.10%	5.96%	7.94%
5-Year Return	-10.78%	12.08%	13.14%
10-Year Return	1.05%	10.91%	12.25%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	1.12B	729.00M	810.00M	587.00M	787.65M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":64.92,"profit":true},{"date":"2021-12-31","value":72.13,"profit":true},{"date":"2022-12-31","value":52.27,"profit":true},{"date":"2023-12-31","value":70.14,"profit":true}]
Cost of Revenue	4.00M	12.00M	11.00M	14.00M	9.13M	[{"date":"2019-12-31","value":28.57,"profit":true},{"date":"2020-12-31","value":85.71,"profit":true},{"date":"2021-12-31","value":78.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":65.24,"profit":true}]
Gross Profit	1.12B	717.00M	799.00M	573.00M	778.51M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":64.08,"profit":true},{"date":"2021-12-31","value":71.4,"profit":true},{"date":"2022-12-31","value":51.21,"profit":true},{"date":"2023-12-31","value":69.57,"profit":true}]
Gross Margin	99.64%	98.35%	98.64%	97.61%	98.84%	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.71,"profit":true},{"date":"2021-12-31","value":98.99,"profit":true},{"date":"2022-12-31","value":97.96,"profit":true},{"date":"2023-12-31","value":99.19,"profit":true}]

Operating Expenses	753.00M	889.00M	829.00M	984.00M	1.13B	[{"date":"2019-12-31","value":66.51,"profit":true},{"date":"2020-12-31","value":78.52,"profit":true},{"date":"2021-12-31","value":73.22,"profit":true},{"date":"2022-12-31","value":86.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	366.00M	(172.00M)	(30.00M)	(411.00M)	(353.73M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-46.99,"profit":false},{"date":"2021-12-31","value":-8.2,"profit":false},{"date":"2022-12-31","value":-112.3,"profit":false},{"date":"2023-12-31","value":-96.65,"profit":false}]
Total Non-Operating Income/Expense	(67.77M)	(42.99M)	(14.31M)	144.88M	19.73M	[{"date":"2019-12-31","value":-46.78,"profit":false},{"date":"2020-12-31","value":-29.67,"profit":false},{"date":"2021-12-31","value":-9.88,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":13.61,"profit":true}]
Pre-Tax Income	347.00M	(170.00M)	(30.00M)	(258.00M)	(333.96M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-48.99,"profit":false},{"date":"2021-12-31","value":-8.65,"profit":false},{"date":"2022-12-31","value":-74.35,"profit":false},{"date":"2023-12-31","value":-96.24,"profit":false}]
Income Taxes	44.00M	317.00M	(1.00M)	12.00M	32.32M	[{"date":"2019-12-31","value":13.88,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.32,"profit":false},{"date":"2022-12-31","value":3.79,"profit":true},{"date":"2023-12-31","value":10.2,"profit":true}]
Income After Taxes	303.00M	(487.00M)	(29.00M)	(270.00M)	(366.29M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-160.73,"profit":false},{"date":"2021-12-31","value":-9.57,"profit":false},{"date":"2022-12-31","value":-89.11,"profit":false},{"date":"2023-12-31","value":-120.89,"profit":false}]

Income From Continuous Operations	303.26M	(486.77M)	(28.60M)	(269.72M)	(366.29M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-160.51,"profit":false},{"date":"2021-12-31","value":-9.43,"profit":false},{"date":"2022-12-31","value":-88.94,"profit":false},{"date":"2023-12-31","value":-120.78,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	294.00M	(487.00M)	(29.00M)	(270.00M)	(366.29M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-165.65,"profit":false},{"date":"2021-12-31","value":-9.86,"profit":false},{"date":"2022-12-31","value":-91.84,"profit":false},{"date":"2023-12-31","value":-124.59,"profit":false}]

EPS (Diluted)	2.20	(0.36)	(0.38)	(2.89)	(2.56)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-16.36,"profit":false},{"date":"2021-12-31","value":-17.27,"profit":false},{"date":"2022-12-31","value":-131.36,"profit":false},{"date":"2023-12-31","value":-116.36,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	(35.08%)	11.11%	(27.53%)	34.18%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-102.64,"profit":false},{"date":"2021-12-31","value":32.51,"profit":true},{"date":"2022-12-31","value":-80.54,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	200.00%	(8.33%)	27.27%	(34.76%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-4.17,"profit":false},{"date":"2022-12-31","value":13.64,"profit":true},{"date":"2023-12-31","value":-17.38,"profit":false}]
Gross Profit	-	(35.92%)	11.44%	(28.29%)	35.87%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-100.16,"profit":false},{"date":"2021-12-31","value":31.89,"profit":true},{"date":"2022-12-31","value":-78.86,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	(1.29%)	0.29%	(1.04%)	1.26%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-103.11,"profit":false},{"date":"2021-12-31","value":23.33,"profit":true},{"date":"2022-12-31","value":-82.93,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	18.06%	(6.75%)	18.70%	15.06%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":96.6,"profit":true},{"date":"2021-12-31","value":-36.1,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.57,"profit":true}]
Operating Income	-	(146.99%)	(82.56%)	1270.00%	(13.93%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-11.57,"profit":false},{"date":"2021-12-31","value":-6.5,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.1,"profit":false}]
Total Non-Operating Income/Expense	-	(36.56%)	(66.71%)	(1112.21%)	(86.39%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(148.99%)	(82.35%)	760.00%	29.44%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-19.6,"profit":false},{"date":"2021-12-31","value":-10.84,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.87,"profit":true}]
Income Taxes	-	620.45%	(100.32%)	(1300.00%)	169.34%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-16.17,"profit":false},{"date":"2022-12-31","value":-209.52,"profit":false},{"date":"2023-12-31","value":27.29,"profit":true}]
Income After Taxes	-	(260.73%)	(94.05%)	831.03%	35.66%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-31.37,"profit":false},{"date":"2021-12-31","value":-11.32,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.29,"profit":true}]

Income From Continuous Operations	-	(260.51%)	(94.13%)	843.18%	35.80%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-30.9,"profit":false},{"date":"2021-12-31","value":-11.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.25,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(265.65%)	(94.05%)	831.03%	35.66%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-31.97,"profit":false},{"date":"2021-12-31","value":-11.32,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.29,"profit":true}]

EPS (Diluted)	-	(116.36%)	5.56%	660.53%	(11.42%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-17.62,"profit":false},{"date":"2021-12-31","value":0.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.73,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	152.00M	131.00M	188.00M	144.00M	324.50M	[{"date":"2022-12-31","value":46.84,"profit":true},{"date":"2023-03-31","value":40.37,"profit":true},{"date":"2023-06-30","value":57.93,"profit":true},{"date":"2023-09-30","value":44.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	4.00M	1.00M	3.00M	2.00M	3.06M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":25,"profit":true},{"date":"2023-06-30","value":75,"profit":true},{"date":"2023-09-30","value":50,"profit":true},{"date":"2023-12-31","value":76.55,"profit":true}]
Gross Profit	148.00M	130.00M	185.00M	142.00M	321.44M	[{"date":"2022-12-31","value":46.04,"profit":true},{"date":"2023-03-31","value":40.44,"profit":true},{"date":"2023-06-30","value":57.55,"profit":true},{"date":"2023-09-30","value":44.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	97.37%	99.24%	98.40%	98.61%	99.06%	[{"date":"2022-12-31","value":98.12,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":99.16,"profit":true},{"date":"2023-09-30","value":99.37,"profit":true},{"date":"2023-12-31","value":99.82,"profit":true}]

Operating Expenses	356.00M	244.00M	276.00M	285.00M	327.56M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":68.54,"profit":true},{"date":"2023-06-30","value":77.53,"profit":true},{"date":"2023-09-30","value":80.06,"profit":true},{"date":"2023-12-31","value":92.01,"profit":true}]
Operating Income	(208.00M)	(114.00M)	(91.00M)	(143.00M)	(6.12M)	[{"date":"2022-12-31","value":-20800000000,"profit":false},{"date":"2023-03-31","value":-11400000000,"profit":false},{"date":"2023-06-30","value":-9100000000,"profit":false},{"date":"2023-09-30","value":-14300000000,"profit":false},{"date":"2023-12-31","value":-612300000,"profit":false}]
Total Non-Operating Income/Expense	162.28M	(15.00M)	14.00M	2.00M	3.31M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-9.24,"profit":false},{"date":"2023-06-30","value":8.63,"profit":true},{"date":"2023-09-30","value":1.23,"profit":true},{"date":"2023-12-31","value":2.04,"profit":true}]
Pre-Tax Income	(44.00M)	(113.00M)	(77.00M)	(141.00M)	(2.77M)	[{"date":"2022-12-31","value":-4400000000,"profit":false},{"date":"2023-03-31","value":-11300000000,"profit":false},{"date":"2023-06-30","value":-7700000000,"profit":false},{"date":"2023-09-30","value":-14100000000,"profit":false},{"date":"2023-12-31","value":-276700000,"profit":false}]
Income Taxes	8.00M	11.00M	8.00M	6.00M	6.50M	[{"date":"2022-12-31","value":72.73,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":72.73,"profit":true},{"date":"2023-09-30","value":54.55,"profit":true},{"date":"2023-12-31","value":59.05,"profit":true}]
Income After Taxes	(52.00M)	(124.00M)	(85.00M)	(147.00M)	(9.26M)	[{"date":"2022-12-31","value":-5200000000,"profit":false},{"date":"2023-03-31","value":-12400000000,"profit":false},{"date":"2023-06-30","value":-8500000000,"profit":false},{"date":"2023-09-30","value":-14700000000,"profit":false},{"date":"2023-12-31","value":-926300000,"profit":false}]

Income From Continuous Operations	(52.43M)	(124.00M)	(85.00M)	(147.00M)	(9.26M)	[{"date":"2022-12-31","value":-5243000000,"profit":false},{"date":"2023-03-31","value":-12400000000,"profit":false},{"date":"2023-06-30","value":-8500000000,"profit":false},{"date":"2023-09-30","value":-14700000000,"profit":false},{"date":"2023-12-31","value":-926300000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(52.00M)	(124.00M)	(85.00M)	(147.00M)	(9.26M)	[{"date":"2022-12-31","value":-5200000000,"profit":false},{"date":"2023-03-31","value":-12400000000,"profit":false},{"date":"2023-06-30","value":-8500000000,"profit":false},{"date":"2023-09-30","value":-14700000000,"profit":false},{"date":"2023-12-31","value":-926300000,"profit":false}]

EPS (Diluted)	(1.36)	(0.87)	(0.60)	(1.03)	(0.06)	[{"date":"2022-12-31","value":-136,"profit":false},{"date":"2023-03-31","value":-87,"profit":false},{"date":"2023-06-30","value":-60,"profit":false},{"date":"2023-09-30","value":-103,"profit":false},{"date":"2023-12-31","value":-6,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	-	(13.82%)	43.51%	(23.40%)	125.35%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-11.02,"profit":false},{"date":"2023-06-30","value":34.71,"profit":true},{"date":"2023-09-30","value":-18.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	(75.00%)	200.00%	(33.33%)	53.10%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-37.5,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-16.67,"profit":false},{"date":"2023-12-31","value":26.55,"profit":true}]
Gross Profit	-	(12.16%)	42.31%	(23.24%)	126.37%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-9.62,"profit":false},{"date":"2023-06-30","value":33.48,"profit":true},{"date":"2023-09-30","value":-18.39,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	1.92%	(0.84%)	0.21%	0.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-43.72,"profit":false},{"date":"2023-09-30","value":10.96,"profit":true},{"date":"2023-12-31","value":23.54,"profit":true}]

Operating Expenses	-	(31.46%)	13.11%	3.26%	14.93%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-210.7,"profit":false},{"date":"2023-06-30","value":87.83,"profit":true},{"date":"2023-09-30","value":21.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(45.19%)	(20.18%)	57.14%	(95.72%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-79.09,"profit":false},{"date":"2023-06-30","value":-35.31,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-167.51,"profit":false}]
Total Non-Operating Income/Expense	-	(109.24%)	(193.33%)	(85.71%)	65.70%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-166.28,"profit":false},{"date":"2023-06-30","value":-294.27,"profit":false},{"date":"2023-09-30","value":-130.46,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	156.82%	(31.86%)	83.12%	(98.04%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-20.32,"profit":false},{"date":"2023-09-30","value":53,"profit":true},{"date":"2023-12-31","value":-62.52,"profit":false}]
Income Taxes	-	37.50%	(27.27%)	(25.00%)	8.27%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-72.73,"profit":false},{"date":"2023-09-30","value":-66.67,"profit":false},{"date":"2023-12-31","value":22.04,"profit":true}]
Income After Taxes	-	138.46%	(31.45%)	72.94%	(93.70%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-22.72,"profit":false},{"date":"2023-09-30","value":52.68,"profit":true},{"date":"2023-12-31","value":-67.67,"profit":false}]

Income From Continuous Operations	-	136.51%	(31.45%)	72.94%	(93.70%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-23.04,"profit":false},{"date":"2023-09-30","value":53.43,"profit":true},{"date":"2023-12-31","value":-68.64,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	138.46%	(31.45%)	72.94%	(93.70%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-22.72,"profit":false},{"date":"2023-09-30","value":52.68,"profit":true},{"date":"2023-12-31","value":-67.67,"profit":false}]

EPS (Diluted)	-	(36.03%)	(31.03%)	71.67%	(94.17%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-50.27,"profit":false},{"date":"2023-06-30","value":-43.3,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-131.41,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	2.72B	2.13B	2.35B	2.20B	2.64B	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":78.28,"profit":true},{"date":"2021-12-31","value":86.18,"profit":true},{"date":"2022-12-31","value":80.96,"profit":true},{"date":"2023-12-31","value":97.09,"profit":true}]
Non-current Assets	512.00M	260.00M	267.00M	331.00M	348.22M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":50.78,"profit":true},{"date":"2021-12-31","value":52.15,"profit":true},{"date":"2022-12-31","value":64.65,"profit":true},{"date":"2023-12-31","value":68.01,"profit":true}]
Total Assets	3.23B	2.39B	2.61B	2.53B	2.99B	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":73.93,"profit":true},{"date":"2021-12-31","value":80.79,"profit":true},{"date":"2022-12-31","value":78.38,"profit":true},{"date":"2023-12-31","value":92.49,"profit":true}]

Total Liabilities
Current Liabilities	273.00M	290.00M	241.00M	312.00M	448.09M	[{"date":"2019-12-31","value":60.93,"profit":true},{"date":"2020-12-31","value":64.72,"profit":true},{"date":"2021-12-31","value":53.78,"profit":true},{"date":"2022-12-31","value":69.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	1.27B	1.26B	1.60B	1.65B	2.16B	[{"date":"2019-12-31","value":59.16,"profit":true},{"date":"2020-12-31","value":58.32,"profit":true},{"date":"2021-12-31","value":74.19,"profit":true},{"date":"2022-12-31","value":76.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	1.55B	1.55B	1.84B	1.96B	2.60B	[{"date":"2019-12-31","value":59.46,"profit":true},{"date":"2020-12-31","value":59.42,"profit":true},{"date":"2021-12-31","value":70.68,"profit":true},{"date":"2022-12-31","value":75.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	140.00K	140.00K	141.00K	142.00K	144.00K	[{"date":"2019-12-31","value":97.22,"profit":true},{"date":"2020-12-31","value":97.22,"profit":true},{"date":"2021-12-31","value":97.92,"profit":true},{"date":"2022-12-31","value":98.61,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(707.53M)	(1.25B)	(1.16B)	(1.43B)	(1.80B)	[{"date":"2019-12-31","value":-70753400000,"profit":false},{"date":"2020-12-31","value":-124936800000,"profit":false},{"date":"2021-12-31","value":-115990300000,"profit":false},{"date":"2022-12-31","value":-142962500000,"profit":false},{"date":"2023-12-31","value":-179591100000,"profit":false}]
Other Stockholders' Equity	2.20B	2.11B	1.96B	2.06B	2.18B	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":95.9,"profit":true},{"date":"2021-12-31","value":89.14,"profit":true},{"date":"2022-12-31","value":93.48,"profit":true},{"date":"2023-12-31","value":99.04,"profit":true}]
Total Shareholders' equity	1.47B	843.00M	772.00M	573.00M	386.69M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":57.31,"profit":true},{"date":"2021-12-31","value":52.48,"profit":true},{"date":"2022-12-31","value":38.95,"profit":true},{"date":"2023-12-31","value":26.29,"profit":true}]

Total Liabilities & Shareholders Equity	3.02B	2.39B	2.61B	2.53B	2.99B	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":79.17,"profit":true},{"date":"2021-12-31","value":86.52,"profit":true},{"date":"2022-12-31","value":83.94,"profit":true},{"date":"2023-12-31","value":99.04,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	(21.72%)	10.09%	(6.06%)	19.92%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-109.03,"profit":false},{"date":"2021-12-31","value":50.67,"profit":true},{"date":"2022-12-31","value":-30.4,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	(49.22%)	2.69%	23.97%	5.20%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-205.33,"profit":false},{"date":"2021-12-31","value":11.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":21.7,"profit":true}]
Total Assets	-	(26.07%)	9.29%	(2.99%)	18.00%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-144.88,"profit":false},{"date":"2021-12-31","value":51.61,"profit":true},{"date":"2022-12-31","value":-16.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	6.23%	(16.90%)	29.46%	43.62%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":14.28,"profit":true},{"date":"2021-12-31","value":-38.74,"profit":false},{"date":"2022-12-31","value":67.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	(1.41%)	27.21%	3.13%	30.70%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4.6,"profit":false},{"date":"2021-12-31","value":88.61,"profit":true},{"date":"2022-12-31","value":10.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	(0.06%)	18.94%	6.58%	32.76%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.2,"profit":false},{"date":"2021-12-31","value":57.82,"profit":true},{"date":"2022-12-31","value":20.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	0.71%	0.71%	1.41%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":50.71,"profit":true},{"date":"2022-12-31","value":50.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	-	76.58%	(7.16%)	23.25%	25.62%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-9.35,"profit":false},{"date":"2022-12-31","value":30.37,"profit":true},{"date":"2023-12-31","value":33.46,"profit":true}]
Other Stockholders' Equity	-	(4.10%)	(7.04%)	4.86%	5.95%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-68.98,"profit":false},{"date":"2021-12-31","value":-118.47,"profit":false},{"date":"2022-12-31","value":81.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(42.69%)	(8.42%)	(25.78%)	(32.52%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(20.83%)	9.29%	(2.99%)	18.00%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-115.76,"profit":false},{"date":"2021-12-31","value":51.61,"profit":true},{"date":"2022-12-31","value":-16.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	2.20B	2.54B	2.62B	2.58B	2.64B	[{"date":"2022-12-31","value":83.39,"profit":true},{"date":"2023-03-31","value":96.26,"profit":true},{"date":"2023-06-30","value":99.02,"profit":true},{"date":"2023-09-30","value":97.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	331.00M	342.00M	355.00M	349.00M	348.22M	[{"date":"2022-12-31","value":93.24,"profit":true},{"date":"2023-03-31","value":96.34,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":98.31,"profit":true},{"date":"2023-12-31","value":98.09,"profit":true}]
Total Assets	2.53B	2.88B	2.97B	2.93B	2.99B	[{"date":"2022-12-31","value":84.75,"profit":true},{"date":"2023-03-31","value":96.49,"profit":true},{"date":"2023-06-30","value":99.36,"profit":true},{"date":"2023-09-30","value":98.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	312.00M	764.00M	798.00M	917.00M	448.09M	[{"date":"2022-12-31","value":34.02,"profit":true},{"date":"2023-03-31","value":83.32,"profit":true},{"date":"2023-06-30","value":87.02,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":48.86,"profit":true}]
Non-current Liabilities	1.65B	1.63B	1.75B	1.70B	2.16B	[{"date":"2022-12-31","value":76.51,"profit":true},{"date":"2023-03-31","value":75.81,"profit":true},{"date":"2023-06-30","value":80.96,"profit":true},{"date":"2023-09-30","value":78.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	1.96B	2.40B	2.54B	2.62B	2.60B	[{"date":"2022-12-31","value":74.88,"profit":true},{"date":"2023-03-31","value":91.56,"profit":true},{"date":"2023-06-30","value":97.1,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":99.4,"profit":true}]

Total Shareholders' equity
Common Stock	142.00K	143.00K	143.00K	143.00K	144.00K	[{"date":"2022-12-31","value":98.61,"profit":true},{"date":"2023-03-31","value":99.31,"profit":true},{"date":"2023-06-30","value":99.31,"profit":true},{"date":"2023-09-30","value":99.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(1.43B)	(1.55B)	(1.64B)	(1.79B)	(1.80B)	[{"date":"2022-12-31","value":-142962500000,"profit":false},{"date":"2023-03-31","value":-155394800000,"profit":false},{"date":"2023-06-30","value":-163923800000,"profit":false},{"date":"2023-09-30","value":-178664800000,"profit":false},{"date":"2023-12-31","value":-179591100000,"profit":false}]
Other Stockholders' Equity	2.06B	2.09B	2.12B	2.15B	2.18B	[{"date":"2022-12-31","value":94.39,"profit":true},{"date":"2023-03-31","value":95.75,"profit":true},{"date":"2023-06-30","value":97.05,"profit":true},{"date":"2023-09-30","value":98.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	573.00M	487.00M	428.00M	315.00M	386.69M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":84.99,"profit":true},{"date":"2023-06-30","value":74.69,"profit":true},{"date":"2023-09-30","value":54.97,"profit":true},{"date":"2023-12-31","value":67.48,"profit":true}]

Total Liabilities & Shareholders Equity	2.53B	2.88B	2.97B	2.93B	2.99B	[{"date":"2022-12-31","value":84.75,"profit":true},{"date":"2023-03-31","value":96.49,"profit":true},{"date":"2023-06-30","value":99.36,"profit":true},{"date":"2023-09-30","value":98.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	-	15.43%	2.87%	(1.19%)	2.20%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":18.6,"profit":true},{"date":"2023-09-30","value":-7.68,"profit":false},{"date":"2023-12-31","value":14.25,"profit":true}]
Non-current Assets	-	3.32%	3.80%	(1.69%)	(0.22%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":87.43,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-44.46,"profit":false},{"date":"2023-12-31","value":-5.89,"profit":false}]
Total Assets	-	13.85%	2.98%	(1.25%)	1.91%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":21.52,"profit":true},{"date":"2023-09-30","value":-8.99,"profit":false},{"date":"2023-12-31","value":13.8,"profit":true}]

Total Liabilities
Current Liabilities	-	144.87%	4.45%	14.91%	(51.14%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":3.07,"profit":true},{"date":"2023-09-30","value":10.29,"profit":true},{"date":"2023-12-31","value":-35.3,"profit":false}]
Non-current Liabilities	-	(0.91%)	6.79%	(2.46%)	26.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-3.42,"profit":false},{"date":"2023-06-30","value":25.51,"profit":true},{"date":"2023-09-30","value":-9.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	22.28%	6.05%	2.99%	(0.60%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":27.13,"profit":true},{"date":"2023-09-30","value":13.41,"profit":true},{"date":"2023-12-31","value":-2.68,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.70%	-	-	0.70%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":99.3,"profit":true}]
Retained Earnings	-	8.70%	5.49%	8.99%	0.52%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":96.7,"profit":true},{"date":"2023-06-30","value":61.03,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":5.77,"profit":true}]
Other Stockholders' Equity	-	1.45%	1.35%	1.39%	1.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":89.06,"profit":true},{"date":"2023-06-30","value":83.07,"profit":true},{"date":"2023-09-30","value":85.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(15.01%)	(12.11%)	(26.40%)	22.76%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-65.95,"profit":false},{"date":"2023-06-30","value":-53.24,"profit":false},{"date":"2023-09-30","value":-116.01,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	13.85%	2.98%	(1.25%)	1.91%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":21.52,"profit":true},{"date":"2023-09-30","value":-8.99,"profit":false},{"date":"2023-12-31","value":13.8,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	345.72M	35.89M	30.80M	(274.37M)	(307.51M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":10.38,"profit":true},{"date":"2021-12-31","value":8.91,"profit":true},{"date":"2022-12-31","value":-79.36,"profit":false},{"date":"2023-12-31","value":-88.95,"profit":false}]

Investing Activities
Net Investing Cash Flow	(41.27M)	274.48M	194.91M	(262.64M)	-	[{"date":"2019-12-31","value":-15.04,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":71.01,"profit":true},{"date":"2022-12-31","value":-95.69,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	100.02M	(596.61M)	245.93M	(55.30M)	644.08M	[{"date":"2019-12-31","value":15.53,"profit":true},{"date":"2020-12-31","value":-92.63,"profit":false},{"date":"2021-12-31","value":38.18,"profit":true},{"date":"2022-12-31","value":-8.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	404.47M	(285.62M)	471.53M	(592.72M)	122.79M	[{"date":"2019-12-31","value":85.78,"profit":true},{"date":"2020-12-31","value":-60.57,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-125.7,"profit":false},{"date":"2023-12-31","value":26.04,"profit":true}]

Free Cash Flow
Free Cash Flow	309.44M	(5.16M)	12.90M	(294.47M)	(335.52M)	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1.67,"profit":false},{"date":"2021-12-31","value":4.17,"profit":true},{"date":"2022-12-31","value":-95.16,"profit":false},{"date":"2023-12-31","value":-108.43,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(89.62%)	(14.19%)	(990.84%)	12.08%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-741.89,"profit":false},{"date":"2021-12-31","value":-117.47,"profit":false},{"date":"2022-12-31","value":-8202.54,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(765.01%)	(28.99%)	(234.75%)	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(696.48%)	(141.22%)	(122.48%)	(1264.81%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(170.62%)	(265.09%)	(225.70%)	(120.72%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(101.67%)	(350.16%)	(2383.06%)	13.94%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-729.21,"profit":false},{"date":"2021-12-31","value":-2511.51,"profit":false},{"date":"2022-12-31","value":-17092.61,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	(200.19M)	(133.99M)	(97.36M)	(109.02M)	32.87M	[{"date":"2022-12-31","value":-609.14,"profit":false},{"date":"2023-03-31","value":-407.7,"profit":false},{"date":"2023-06-30","value":-296.25,"profit":false},{"date":"2023-09-30","value":-331.73,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	212.15M	(325.64M)	69.52M	-	-	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-153.5,"profit":false},{"date":"2023-06-30","value":32.77,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(51.02M)	492.09M	143.54M	(32.27M)	40.72M	[{"date":"2022-12-31","value":-10.37,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":29.17,"profit":true},{"date":"2023-09-30","value":-6.56,"profit":false},{"date":"2023-12-31","value":8.28,"profit":true}]

Net Change in Cash	(38.52M)	32.56M	115.76M	(72.73M)	47.21M	[{"date":"2022-12-31","value":-33.28,"profit":false},{"date":"2023-03-31","value":28.13,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-62.83,"profit":false},{"date":"2023-12-31","value":40.78,"profit":true}]

Free Cash Flow
Free Cash Flow	(205.20M)	(145.72M)	(110.44M)	(112.26M)	32.05M	[{"date":"2022-12-31","value":-640.33,"profit":false},{"date":"2023-03-31","value":-454.71,"profit":false},{"date":"2023-06-30","value":-344.62,"profit":false},{"date":"2023-09-30","value":-350.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	-	(33.07%)	(27.34%)	11.97%	(130.15%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-276.18,"profit":false},{"date":"2023-06-30","value":-228.3,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-1086.93,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(253.50%)	(121.35%)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(1064.52%)	(70.83%)	(122.48%)	(226.21%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(184.52%)	255.54%	(162.83%)	(164.91%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-72.21,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-63.72,"profit":false},{"date":"2023-12-31","value":-64.53,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(28.99%)	(24.21%)	1.65%	(128.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-1752.24,"profit":false},{"date":"2023-06-30","value":-1463.53,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-7770.14,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	IONS
Cash Ratio	5.20
Current Ratio	5.90
Quick Ratio	5.83

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	IONS
ROA (LTM)	-7.51%
ROE (LTM)	-76.34%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	IONS
Debt Ratio Lower is generally better. Negative is bad.	0.87
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.13
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	7.73

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	IONS
Trailing PE	NM
Forward PE	90.91
P/S (TTM)	7.72
P/B	15.74
Price/FCF	185
EV/R	6.61
EV/Ebitda	NM
PEG	0.47

News

Chronic Hepatitis B Market Forecasted to Experience Growth by 2032, According to DelveInsight | GlaxoSmithKline, Ionis Pharma, Beijing Continent Pharmaceutical, Ascletis Pharmaceuticals, Vir Biotech

Chronic Hepatitis B Market (Albany, USA) DelveInsight’s “Chronic Hepatitis B Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Chronic Hepatitis B, historical and forecasted epidemiology as well as the Chronic Hepatitis B market trends in the … Continue reading →

12 Apr, 2024 a 8:18 pm AB Newswire

Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies – Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma

New York, USA, April 09, 2024 (GLOBE NEWSWIRE) — Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies – Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma DelveInsight analysts project a favorable treatment-resistant hypertension market expansion, primarily driven by a rise in prevalence and the […]

9 Apr, 2024 a 5:00 pm Business Upturn

Amyotrophic Lateral Sclerosis Market to Witness Growth by 2034, Estimates DelveInsight

Amyotrophic Lateral Sclerosis companies are Biogen, Novartis, Sanofi, Ionis Pharmaceuticals, Ferrer, AbbVie, Calico Life Sciences, Corcept Therapeutics, & more. ALBANY, NEW YORK, UNITED STATES, April 4, 2024 /⁨EINPresswire.com⁩/ -- …

4 Apr, 2024 a 12:30 pm EIN News Marijuana

Anticipated Surge in Beta Thalassemia Market Expected by 2032, Forecasts DelveInsight: Key Players Include Novartis, Merck, Bristol Myers Squibb, Celgene, etc

Beta Thalassemia Market Key Beta Thalassemia companies working in the market are Novartis, Merck, Bristol Myers Squibb, Celgene, Chiesi Farmaceutici S.p.A, Bluebird Bio, Agios Pharmaceuticals, Imara Inc., CRISPR Therapeutics, Vertex Pharmaceuticals, Vifor Pharma, Ionis Pharmaceuticals, Forma Therapeutics, DisperSol Technologies, EdiGene, … Continue reading →

19 Mar, 2024 a 11:22 am AB Newswire

Ionis Pharma''s fatty liver disease drug succeeds in mid-stage trial

… SALTWIRE VIDEOS (Reuters) - Ionis Pharmaceuticals said on Wednesday its experimental … steatohepatitis (NASH), has no approved drugs , with the U.S. Food … to decide on rival Madrigal Pharmacauticals'' ; drug by Thursday. (Reporting …

13 Mar, 2024 a 11:53 am EIN News Pharmaceuticals

Ionis Pharmaceuticals Announces Executive Advisory and Leadership Changes

Ionis Pharmaceuticals (IONS) has provided an update. Ionis Pharmaceuticals has engaged Onaiza Cadoret-Manier under an advisory services agreement a…

29 Feb, 2024 a 2:22 pm TipRanks

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Ionis Pharmaceuticals Inc share price today?

Ionis Pharmaceuticals Inc (IONS) share price today is $41.07

Can Indians buy Ionis Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Ionis Pharmaceuticals Inc (IONS) on Vested. To buy Ionis Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IONS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ionis Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Ionis Pharmaceuticals Inc (IONS) via the Vested app. You can start investing in Ionis Pharmaceuticals Inc (IONS) with a minimum investment of $1.

How to invest in Ionis Pharmaceuticals Inc shares from India?

You can invest in shares of Ionis Pharmaceuticals Inc (IONS) via Vested in three simple steps:

Click on Sign Up or Invest in IONS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Ionis Pharmaceuticals Inc shares

What is Ionis Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Ionis Pharmaceuticals Inc (IONS) is $54.44. The 52-week low price of Ionis Pharmaceuticals Inc (IONS) is $34.32.

What is Ionis Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ionis Pharmaceuticals Inc (IONS) is NM

What is Ionis Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ionis Pharmaceuticals Inc (IONS) is 15.74

What is Ionis Pharmaceuticals Inc dividend yield?

The dividend yield of Ionis Pharmaceuticals Inc (IONS) is 0.00%

What is the Market Cap of Ionis Pharmaceuticals Inc?

The market capitalization of Ionis Pharmaceuticals Inc (IONS) is $5.99B

What is Ionis Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Ionis Pharmaceuticals Inc is IONS

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Ionis Pharmaceuticals Inc, Common Stock

IONS

NSQ

$41.07

+$0.39

(0.96%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Ionis Pharmaceuticals Inc, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Chronic Hepatitis B Market Forecasted to Experience Growth by 2032, According to DelveInsight | GlaxoSmithKline, Ionis Pharma, Beijing Continent Pharmaceutical, Ascletis Pharmaceuticals, Vir Biotech

Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies – Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma

Amyotrophic Lateral Sclerosis Market to Witness Growth by 2034, Estimates DelveInsight

Anticipated Surge in Beta Thalassemia Market Expected by 2032, Forecasts DelveInsight: Key Players Include Novartis, Merck, Bristol Myers Squibb, Celgene, etc

Ionis Pharma''s fatty liver disease drug succeeds in mid-stage trial

Ionis Pharmaceuticals Announces Executive Advisory and Leadership Changes

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²